These data suggest a possible role of Ep-PUFAs, dihydroxy-PUFAs, or hydroxy-PUFAs in neuroprotection and reduced risk of AD, as CYP2J2 is one of the key isoforms of CYP responsible for Ep-PUFAs metabolism. The gene discussed is CYP2J2; the disease is Alzheimer disease.